Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Moertel

Showing results (111-120 of 251) with videos related to

Pageof 26
Sort By:
Mayo Clinic Proceedings|September 1, 1976
Ultrastructural cytochemistry of platelets and megakaryocytes in the carcinoid syndromeJ C Lewis, J E Maldonado, K G Mann, et al.
Cancer Chemotherapy Reports|February 1, 1972
Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancerC G Moertel, A J Schutt, R J Reitemeier, et al.
Cancer Chemotherapy Reports|June 1, 1971
Phase II study of strepozotocin (NSC-85998) in the treatment of advanced gastrointestinal cancerC G Moertel, R J Reitemeier, A J Schutt, et al.
Surgery, Gynecology & Obstetrics|April 1, 1974
A prospective study of appendectomy and predisposition to cancerC G Moertel, F T Nobrega, L R Elveback, et al.
Cancer|December 1, 1972
Treatment of the patient with adenocarcinoma of unknown originC G Moertel, R J Reitemeier, A J Schutt, et al.
Cancer Chemotherapy Reports|March 1, 1974
Effects of patient selection on results of phase II chemotherapy trials in gastrointestinal cancerC G Moertel, A J Schutt, R G Hahn, et al.
The New England Journal of Medicine|June 9, 1977
Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedulesE P DiMagno, J R Malagelada, V L Go, et al.
Mayo Clinic Proceedings|March 1, 1991
Effect of the somatostatin analogue octreotide acetate on hemostasis in humansT E Witzig, L K Kvols, C G Moertel, et al.
Cancer|April 1, 1975
A double-blind comparison of intensive course 5-flourouracil by oral vs. intravenous route in the treatment of colorectal carcinomaR G Hahn, C G Moertel, A J Schutt, et al.
Journal of the National Cancer Institute|January 1, 1976
Phase I study of a five-day intermittent schedule for 1,2:5,6-dianhydrogalactitol (NSC-132313)R T Eagan, C G Moertel, R G Hahn, et al.
Pageof 26

Showing results (111-120 of 251) with videos related to

Sort By:
Pageof 26
Mayo Clinic Proceedings|September 1, 1976
Ultrastructural cytochemistry of platelets and megakaryocytes in the carcinoid syndromeJ C Lewis, J E Maldonado, K G Mann, et al.
Cancer Chemotherapy Reports|February 1, 1972
Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancerC G Moertel, A J Schutt, R J Reitemeier, et al.
Cancer Chemotherapy Reports|June 1, 1971
Phase II study of strepozotocin (NSC-85998) in the treatment of advanced gastrointestinal cancerC G Moertel, R J Reitemeier, A J Schutt, et al.
Surgery, Gynecology & Obstetrics|April 1, 1974
A prospective study of appendectomy and predisposition to cancerC G Moertel, F T Nobrega, L R Elveback, et al.
Cancer|December 1, 1972
Treatment of the patient with adenocarcinoma of unknown originC G Moertel, R J Reitemeier, A J Schutt, et al.
Cancer Chemotherapy Reports|March 1, 1974
Effects of patient selection on results of phase II chemotherapy trials in gastrointestinal cancerC G Moertel, A J Schutt, R G Hahn, et al.
The New England Journal of Medicine|June 9, 1977
Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedulesE P DiMagno, J R Malagelada, V L Go, et al.
Mayo Clinic Proceedings|March 1, 1991
Effect of the somatostatin analogue octreotide acetate on hemostasis in humansT E Witzig, L K Kvols, C G Moertel, et al.
Cancer|April 1, 1975
A double-blind comparison of intensive course 5-flourouracil by oral vs. intravenous route in the treatment of colorectal carcinomaR G Hahn, C G Moertel, A J Schutt, et al.
Journal of the National Cancer Institute|January 1, 1976
Phase I study of a five-day intermittent schedule for 1,2:5,6-dianhydrogalactitol (NSC-132313)R T Eagan, C G Moertel, R G Hahn, et al.
Pageof 26